{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:09:25Z","timestamp":1790932165586,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":2047,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1038\/mt.2010.257","type":"journal-article","created":{"date-parts":[[2010,11,30]],"date-time":"2010-11-30T15:25:55Z","timestamp":1291130755000},"page":"461-469","source":"Crossref","is-referenced-by-count":66,"title":["Long-term Amelioration of Feline Mucopolysaccharidosis VI After AAV-mediated Liver Gene Transfer"],"prefix":"10.1016","volume":"19","author":[{"given":"Gabriella","family":"Cotugno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Annunziata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Tessitore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"O'Malley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Capalbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armida","family":"Faella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Bartolomeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"O'Donnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meg M","family":"Sleeper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Van W","family":"Knox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Levanduski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Hopwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvira","family":"De Leonibus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Haskins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Auricchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2010.257_bib1","series-title":"The mucopolysaccharidoses, Scriver","author":"Neufeld","year":"2001"},{"key":"10.1038\/mt.2010.257_bib2","first-page":"381","article-title":"The mucopolysaccharidoses. Diagnosis, molecular genetics and treatment","volume":"7","author":"Hopwood","year":"1990","journal-title":"Mol Biol Med"},{"key":"10.1038\/mt.2010.257_bib3","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jpeds.2005.12.014","volume":"148","author":"Harmatz","year":"2006","journal-title":"J Pediatr"},{"key":"10.1038\/mt.2010.257_bib4","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/nrg963","article-title":"Enzyme replacement and enhancement therapies: lessons from lysosomal disorders","volume":"3","author":"Desnick","year":"2002","journal-title":"Nat Rev Genet"},{"key":"10.1038\/mt.2010.257_bib5","doi-asserted-by":"crossref","first-page":"12115","DOI":"10.1016\/S0021-9258(18)63825-6","article-title":"Mannose 6-phosphate receptors and lysosomal enzyme targeting","volume":"264","author":"Dahms","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1038\/mt.2010.257_bib6","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1185\/03007990902892633","article-title":"Expensive drugs for rare disorders: to treat or not to treat? The case of enzyme replacement therapy for mucopolysaccharidosis VI","volume":"25","author":"Schlander","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"10.1038\/mt.2010.257_bib7","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s00417-008-1030-1","article-title":"Does enzyme replacement therapy influence the ocular changes in type VI mucopolysaccharidosis?","volume":"247","author":"Pitz","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1038\/mt.2010.257_bib8","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1399-0004.2009.01324.x","article-title":"Enzyme replacement therapy for mucopolysaccharidosis VI from 8 weeks of age\u2013a sibling control study","volume":"77","author":"McGill","year":"2010","journal-title":"Clin Genet"},{"key":"10.1038\/mt.2010.257_bib9","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1172\/JCI119208","article-title":"Enzyme replacement therapy from birth in a feline model of mucopolysaccharidosis type VI","volume":"99","author":"Crawley","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2010.257_bib10","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1172\/JCI116268","article-title":"Arylsulfatase B-deficient mucopolysaccharidosis in rats","volume":"91","author":"Yoshida","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2010.257_bib11","doi-asserted-by":"crossref","first-page":"27259","DOI":"10.1074\/jbc.271.44.27259","article-title":"Feline mucopolysaccharidosis type VI. Characterization of recombinant N-acetylgalactosamine 4-sulfatase and identification of a mutation causing the disease","volume":"271","author":"Yogalingam","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1038\/mt.2010.257_bib12","doi-asserted-by":"crossref","first-page":"8214","DOI":"10.1073\/pnas.93.16.8214","article-title":"Targeted disruption of the arylsulfatase B gene results in mice resembling the phenotype of mucopolysaccharidosis VI","volume":"93","author":"Evers","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2010.257_bib13","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/sj.mt.6300325","article-title":"Biochemical, pathological, and skeletal improvement of mucopolysaccharidosis VI after gene transfer to liver but not to muscle","volume":"16","author":"Tessitore","year":"2008","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2010.257_bib14","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1089\/hum.2009.189","article-title":"Different serum enzyme levels are required to rescue the various systemic features of the mucopolysaccharidoses","volume":"21","author":"Cotugno","year":"2010","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2010.257_bib15","doi-asserted-by":"crossref","first-page":"11854","DOI":"10.1073\/pnas.182412299","article-title":"Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy","volume":"99","author":"Gao","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2010.257_bib16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ymthe.2005.08.017","article-title":"Biology of AAV serotype vectors in liver-directed gene transfer to nonhuman primates","volume":"13","author":"Gao","year":"2006","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2010.257_bib17","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1182\/blood-2006-03-010181","article-title":"Safe and efficient transduction of the liver after peripheral vein infusion of self-complementary AAV vector results in stable therapeutic expression of human FIX in nonhuman primates","volume":"109","author":"Nathwani","year":"2007","journal-title":"Blood"},{"key":"10.1038\/mt.2010.257_bib18","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1006\/mthe.2002.0809","article-title":"Evaluation of pathological manifestations of disease in mucopolysaccharidosis VII mice after neonatal hepatic gene therapy","volume":"6","author":"Xu","year":"2002","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2010.257_bib19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ymthe.2004.08.027","article-title":"Liver-directed neonatal gene therapy prevents cardiac, bone, ear, and eye disease in mucopolysaccharidosis I mice","volume":"11","author":"Liu","year":"2005","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2010.257_bib20","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/sj.mt.6300112","article-title":"Improvements in mucopolysaccharidosis I mice after adult retroviral vector-mediated gene therapy with immunomodulation","volume":"15","author":"Ma","year":"2007","journal-title":"Mol Ther"},{"issue":"Suppl 2","key":"10.1038\/mt.2010.257_bib21","first-page":"S23","article-title":"Optimization of the human factor VIII complementary DNA expression plasmid for gene therapy of hemophilia A","volume":"8","author":"Ill","year":"1997","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1038\/mt.2010.257_bib22","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1089\/10430349950016942","article-title":"Enhanced expression of transgenes from adeno-associated virus vectors with the woodchuck hepatitis virus posttranscriptional regulatory element: implications for gene therapy","volume":"10","author":"Loeb","year":"1999","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2010.257_bib23","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0092-8674(03)00348-9","article-title":"The multiple sulfatase deficiency gene encodes an essential and limiting factor for the activity of sulfatases","volume":"113","author":"Cosma","year":"2003","journal-title":"Cell"},{"key":"10.1038\/mt.2010.257_bib24","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s10545-008-0821-1","article-title":"Clinical characterization of cardiovascular abnormalities associated with feline mucopolysaccharidosis I and VI","volume":"31","author":"Sleeper","year":"2008","journal-title":"J Inherit Metab Dis"},{"key":"10.1038\/mt.2010.257_bib25","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s004310050872","article-title":"Cardiovascular changes in children with mucopolysaccharide storage diseases and related disorders\u2013clinical and echocardiographic findings in 64 patients","volume":"157","author":"Dangel","year":"1998","journal-title":"Eur J Pediatr"},{"key":"10.1038\/mt.2010.257_bib26","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ymgme.2008.07.003","article-title":"Radiographic evaluation of bones and joints in mucopolysaccharidosis I and VII dogs after neonatal gene therapy","volume":"95","author":"Herati","year":"2008","journal-title":"Mol Genet Metab"},{"key":"10.1038\/mt.2010.257_bib27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s002239900656","article-title":"Histomorphometric analysis of the tibial growth plate in a feline model of mucopolysaccharidosis type VI","volume":"65","author":"Nuttall","year":"1999","journal-title":"Calcif Tissue Int"},{"key":"10.1038\/mt.2010.257_bib28","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF00310256","article-title":"Growth plate pathology in feline mucopolysaccharidosis VI","volume":"57","author":"Abreu","year":"1995","journal-title":"Calcif Tissue Int"},{"key":"10.1038\/mt.2010.257_bib29","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ymgme.2008.04.001","article-title":"Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: Final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase","volume":"94","author":"Harmatz","year":"2008","journal-title":"Mol Genet Metab"},{"key":"10.1038\/mt.2010.257_bib30","doi-asserted-by":"crossref","first-page":"e681","DOI":"10.1542\/peds.2004-1023","volume":"115","author":"Harmatz","year":"2005","journal-title":"Pediatrics"},{"key":"10.1038\/mt.2010.257_bib31","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jpeds.2004.03.018","article-title":"Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)","volume":"144","author":"Harmatz","year":"2004","journal-title":"J Pediatr"},{"key":"10.1038\/mt.2010.257_bib32","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1089\/hum.2008.161","article-title":"Improved induction of immune tolerance to factor IX by hepatic AAV-8 gene transfer","volume":"20","author":"Cooper","year":"2009","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2010.257_bib33","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/sj.gt.3302774","article-title":"Early, sustained efficacy of adeno-associated virus vector-mediated gene therapy in glycogen storage disease type Ia","volume":"13","author":"Koeberl","year":"2006","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2010.257_bib34","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.ymthe.2005.04.024","article-title":"Evasion of immune responses to introduced human acid alpha-glucosidase by liver-restricted expression in glycogen storage disease type II","volume":"12","author":"Franco","year":"2005","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2010.257_bib35","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1172\/JCI200316887","article-title":"Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transfer","volume":"111","author":"Mingozzi","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2010.257_bib36","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/humu.1190","article-title":"Mucopolysaccharidosis type VI: Structural and clinical implications of mutations in N-acetylgalactosamine-4-sulfatase","volume":"18","author":"Litjens","year":"2001","journal-title":"Hum Mutat"},{"key":"10.1038\/mt.2010.257_bib37","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/jgm.1343","article-title":"Transient expression of genes delivered to newborn rat liver using recombinant adeno-associated virus 2\/8 vectors","volume":"11","author":"Flageul","year":"2009","journal-title":"J Gene Med"},{"key":"10.1038\/mt.2010.257_bib38","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1089\/hum.2009.031","article-title":"Effect of adeno-associated virus serotype and genomic structure on liver transduction and biodistribution in mice of both genders","volume":"20","author":"Pa\u00f1eda","year":"2009","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2010.257_bib39","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1182\/blood-2002-09-2889","article-title":"Sex significantly influences transduction of murine liver by recombinant adeno-associated viral vectors through an androgen-dependent pathway","volume":"102","author":"Davidoff","year":"2003","journal-title":"Blood"},{"key":"10.1038\/mt.2010.257_bib40","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/mt.2009.245","article-title":"The pleiotropic effects of natural AAV infections on liver-directed gene transfer in macaques","volume":"18","author":"Wang","year":"2010","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2010.257_bib41","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1203\/00006450-197911000-00001","article-title":"Mucopolysaccharide storage disease in three families of cats with arylsulfatase B deficiency: leukocyte studies and carrier identification","volume":"13","author":"Haskins","year":"1979","journal-title":"Pediatr Res"},{"key":"10.1038\/mt.2010.257_bib42","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1203\/01.PDR.0000084085.65972.3F","article-title":"Cardiac and ocular pathologies in a mouse model of mucopolysaccharidosis type VI","volume":"54","author":"Strauch","year":"2003","journal-title":"Pediatr Res"},{"key":"10.1038\/mt.2010.257_bib43","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1172\/JCI118617","article-title":"Enzyme replacement therapy in a feline model of Maroteaux-Lamy syndrome","volume":"97","author":"Crawley","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2010.257_bib44","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S8756-3282(97)00175-0","article-title":"Effect of enzyme replacement therapy on bone formation in a feline model of mucopolysaccharidosis type VI","volume":"21","author":"Byers","year":"1997","journal-title":"Bone"},{"key":"10.1038\/mt.2010.257_bib45","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1086\/595830","article-title":"Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses","volume":"199","author":"Calcedo","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1038\/mt.2010.257_bib46","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1089\/104303401450988","article-title":"Isolation of highly infectious and pure adeno-associated virus type 2 vectors with a single-step gravity-flow column","volume":"12","author":"Auricchio","year":"2001","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2010.257_bib47","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1128\/JVI.73.5.3994-4003.1999","article-title":"Gene therapy vectors based on adeno-associated virus type 1","volume":"73","author":"Xiao","year":"1999","journal-title":"J Virol"},{"key":"10.1038\/mt.2010.257_bib48","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1089\/104303400750001390","article-title":"Purification of recombinant adeno-associated virus vectors by column chromatography and its performance in vivo","volume":"11","author":"Gao","year":"2000","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2010.257_bib49","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/0003-2697(81)90795-8","article-title":"Differential assay of arylsulfatase A and B activities: a sensitive method for cultured human cells","volume":"117","author":"Chang","year":"1981","journal-title":"Anal Biochem"},{"key":"10.1038\/mt.2010.257_bib50","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ymgme.2006.02.013","article-title":"Newborn screening for lysosomal storage disorders","volume":"88","author":"Meikle","year":"2006","journal-title":"Mol Genet Metab"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500161630394X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500161630394X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,14]],"date-time":"2021-11-14T11:28:58Z","timestamp":1636889338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152500161630394X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S152500161630394X"],"URL":"https:\/\/doi.org\/10.1038\/mt.2010.257","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}